Cisplatin: mode of cytotoxic action and molecular basis of resistance

ZH Siddik - Oncogene, 2003 - nature.com
Cisplatin is one of the most potent antitumor agents known, displaying clinical activity
against a wide variety of solid tumors. Its cytotoxic mode of action is mediated by its …

Mammalian caspases: structure, activation, substrates, and functions during apoptosis

WC Earnshaw, LM Martins… - Annual review of …, 1999 - annualreviews.org
▪ Abstract Apoptosis is a genetically programmed, morphologically distinct form of cell death
that can be triggered by a variety of physiological and pathological stimuli. Studies …

Biochemical modulation of cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance

MA Fuertes, C Alonso, JM Pérez - Chemical reviews, 2003 - ACS Publications
Biochemical modulation is the manipulation of cellular biochemical pathways by chemical
agents to produce selective enhancement of the efficacy of an antitumor drug. 1 Since the …

Biochemical mechanisms of cisplatin cytotoxicity

V Cepeda, MA Fuertes, J Castilla… - Anti-Cancer Agents …, 2007 - ingentaconnect.com
Since the discovery by Rosenberg and collaborators of the antitumor activity of cisplatin 35
years ago, three platinum antitumor drugs (cisplatin, carboplatin and oxaliplatin) have …

[HTML][HTML] Role of autophagy in cisplatin resistance in ovarian cancer cells

J Wang, GS Wu - Journal of Biological chemistry, 2014 - ASBMB
Cisplatin-based treatment is the first line chemotherapy for several cancers including
ovarian cancer. The development of cisplatin resistance results in treatment failure, but the …

Is cisplatin-induced cell death always produced by apoptosis?

VM Gonzalez, MA Fuertes, C Alonso, JM Perez - Molecular pharmacology, 2001 - ASPET
The platinum drugs represent a unique and important class of antitumor agents. The clinical
development of the neutral, square planar, coordination complex cis …

Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways

MA Fuertes, J Castilla, C Alonso… - Current medicinal …, 2003 - ingentaconnect.com
Although cisplatin, cis-diamminedichloroplatinum (II), has been successfully used in the
chemotherapy of cancer for more than 25 years, its biochemical mechanism of action is still …

[HTML][HTML] Identification of a PKB/Akt Hydrophobic Motif Ser-473 Kinase as DNA-dependent Protein Kinase*♦

J Feng, J Park, P Cron, D Hess… - Journal of Biological …, 2004 - ASBMB
Full activation of protein kinase B (PKB)/Akt requires phosphorylation on Thr-308 and Ser-
473 by 3-phosphoinositide-dependent kinase-1 (PDK1) and Ser-473 kinase (S473K) …

Platinum‐based anticancer agents: Innovative design strategies and biological perspectives

YP Ho, SCF Au‐Yeung, KKW To - Medicinal research reviews, 2003 - Wiley Online Library
The impact of cisplatin on cancer chemotherapy cannot be denied. Over the past 20 years,
much effort has been dedicated to discover new platinum‐based anticancer agents that are …

Platinum–DNA interactions and subsequent cellular processes controlling sensitivity to anticancer platinum complexes

S Ahmad - Chemistry & biodiversity, 2010 - Wiley Online Library
Platinum‐based compounds are widely used as chemotherapeutics for the treatment of a
variety of cancers. The anticancer activity of cisplatin and other platinum drugs is believed to …